LncRNA | MiRNA | Gene | Gene name | Pathway Name | Description | Title | Disease/Tissue | Journal | PubMed ID |
H19 | miR-675 | CAMK2D | CAMK2D;CAMKD | details
Wnt signaling pathway;ErbB signaling pathway; Calcium signaling pathway;HIF-1 signaling pathway;GnRH signaling pathway;Proteoglycans in cancer;Oocyte meiosis;Circadian entrainment;Long-term potentiation;Glioma;Neurotrophin signaling pathway;Cholinergic synapse;Amphetamine addiction;Gastric acid secretion;Dopaminergic synapse;Melanogenesis;Tuberculosis;Insulin secretion; Olfactory transduction
|
details
We also identified that CaMKIIδ was a direct target of miR-675 and partially mediated the effect of H19 on cardiomyocyte hypertrophy.
|
details
The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy
|
Cardiomyocyte Hypertrophy | Cardiovasc Res | 27084844 |
H19 | miR-675 | HDAC | HDAC9;HD7;HD7b;HD9;HDAC;HDAC7;HDAC7B;HDAC9B;HDAC9FL;HDRP;MITR | details | details
Overexpression of H19 and miR-675 inhibited adipogenesis, while knockdown of their endogenous expression accelerated adipogenic differentiation. Mechanistically, we found that miR-675 targeted the 3' untranslated regions of the histone deacetylase (HDAC) 4-6 transcripts and resulted in deregulation of HDACs 4-6, essential molecules in adipogenesis.
|
details
Long Non-coding RNA H19 Inhibits Adipocyte Differentiation of Bone Marrow Mesenchymal Stem Cells through Epigenetic Modulation of Histone Deacetylases
|
Bone Marrow Mesenchymal Stem Cells | Sci Rep | 27349231 |
H19 | miR-675 | HuR | ELAVL1;ELAV1;HUR;Hua;MelG | details | details
Increasing the level of the RNA-binding protein HuR in cells overexpressing H19 prevented the stimulation of miR-675 processing from H19, promoted ZO-1 and E-cadherin expression, and restored the epithelial barrier function to a nearly normal level.
|
details
H19 Long Noncoding RNA Regulates Intestinal Epithelial Barrier Function via MicroRNA 675 by Interacting with RNA-Binding Protein HuR
|
Intestinal Epithelial Barrier | Mol Cell Biol | 26884465 |
H19 | miR-675 | p53 | TP53;BCC7;LFS1;P53;TRP53 | details
MAPK signaling pathway;Cell cycle;Epstein-Barr virus infection;p53 signaling pathway;PI3K-Akt signaling pathway;Apoptosis;Thyroid cancer;Melanoma;Basal cell carcinoma;Measles;Chronic myeloid leukemia;Wnt signaling pathway;Neurotrophin signaling pathway;HTLV-I infection;Non-small cell lung cancer;Proteoglycans in cancer;Prostate cancer;Amyotrophic lateral sclerosis (ALS);Transcriptional misregulation in cancer;Pathways in cancer;Pancreatic cancer;Huntington's disease;Hepatitis C;Colorectal cancer;Glioma;Bladder cancer;Endometrial cancer;Hepatitis B;Viral carcinogenesis;Small cell lung cancer;Herpes simplex infection
|
details
Ectopic expression of H19 significantly increased bladder cancer cell proliferation and miR-675 expression in vitro. Furthermore, overexpression of miR-675 promoted bladder cancer cell proliferation, while suppression of miR-675 induced G1 phase cell cycle arrest and promoted cell apoptosis. Western blotting analysis further identified that miR-675 inhibited p53 activation, decreased the ratio of Bax/Bcl-2 and cyclin D1 expression in bladder cancer cells; those effects may result in the abnormal proliferation of bladder cancer cells.
|
details
H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation
|
Bladder Cancer | Tumour Biol | 26198047 |
H19 | miR-675 | PTEN | PTEN;10q23del;BZS;CWS1;DEC;GLM2;MHAM;MMAC1;PTEN1;TEP1 | details
p53 signaling pathway;Inositol phosphate metabolism;Prostate cancer;Phosphatidylinositol signaling system;mTOR signaling pathway;PI3K-Akt signaling pathway;Focal adhesion;Tight junction;Hepatitis B;Pathways in cancer;Melanoma;Endometrial cancer;Glioma;Small cell lung cancer
|
details
LncRNA H19-derived microRNA (miR-675) are overexpressed in neointima of balloon-injured artery. We further validated that PTEN is the target gene of miR-675 as demonstrated by luciferase assay. Finally, the results of the rescue experiment indicated that LncRNA H19 promoted the proliferation of T/G HA-VSMC in a miR-675-dependent manner.
|
details
Long noncoding RNA H19-derived miR-675 aggravates restenosis by targeting PTEN
|
Vascular Smooth Muscle Cells | Biochem Biophys Res Commun | 28063931 |
H19 | miR-675 | RUNX1 | RUNX1;AML1;AML1-EVI-1;AMLCR1;CBF2alpha;CBFA2;EVI-1;PEBP2aB;PEBP2alpha | details
Pathways in cancer;Transcriptional misregulation in cancer;Chronic myeloid leukemia;Acute myeloid leukemia
|
details
To our knowledge, this is the time to demonstrate that RUNX1 serves as a link between H19/miR-675 axis and Akt/mTOR signaling and is a pivotal mediator in gastric cancer progression induced by H19/miR-675.
|
details
Long Noncoding RNA H19-Derived miR-675 Enhances Proliferation and Invasion via RUNX1 in Gastric Cancer Cells
|
Gastric Cancer | Oncol Res | 26931432 |
H19 | miR-675 | USP10 | USP10;UBPO | details | details
In summary, melatonin antagonized premature senescence of CPCs via H19/miR-675/USP10 pathway, which provides new insights into pharmacological actions and potential applications of melatonin on the senescence of CPCs.
|
details
Long noncoding RNA H19 mediates melatonin inhibition of premature senescence of c-kit(+) cardiac progenitor cells by promoting miR-675
|
Cardiac Progenitor Cells | J Pineal Res | 27062045 |
H19 | miR-675 | VDAC1 | VDAC1;PORIN;VDAC-1 | details
Calcium signaling pathway;Parkinson's disease;Huntington's disease;Influenza A;HTLV-I infection
|
details
In conclusion, our study demonstrates that H19/miR-675 axis is involved in the regulation of high glucose-induced apoptosis by targeting VDAC1, which may provide a novel therapeutic strategy for the treatment of DCM.
|
details
lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy
|
Diabetic Cardiomyopathy | Sci Rep | 27796346 |